MedTrace Logo

Outcomes Following Phacoemulsification With 1.8 & 2.2mm Incision: Randomized Clinical Trial

NCT01385878 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2011-06-30

No results posted yet for this study

Summary

Cataract surgical techniques have significantly changed in recent years with the widespread adoption of smaller and smaller clear corneal incisions for phacoemulsification. Microincision surgery has many advantages, including reduced surgically induced astigmatism, faster visual recovery, and reduced intra and postoperative inflammation. Curently, microcoaxial phacoemulsification is being performed through 1.8 as well as 2.2 mm incisions. However, there is still a debate as to which is the best absolute incision size for microcoaxial cataract surgery.

The aim of this study is to evaluate incision stability following microcoaxial phacoemulsification performed through 1.8 and 2.2 mm systems, as well as compare intraoperative performance and postoperative outcomes following microcoaxial phacoemulsification performed through these two incision sizes.

Conditions

  • Cataract

Interventions

PROCEDURE

Microcoaxial Phacoemulsification

Phacoemulsification through small clear corneal incision

PROCEDURE

Microcoaxial Phacoemulsification

Phacoemulsification through clear corneal incision

PROCEDURE

Microcoaxial Phacoemulsification

Microcoaxial Phacoemulsification through 1.8mm incision

PROCEDURE

Microcoaxial Phacoemulsification

Microcoaxial phacoemulsification through 2.2mm incision

Sponsors & Collaborators

  • Iladevi Cataract and IOL Research Center

    lead OTHER

Principal Investigators

  • Abhay R Vasavada, MS, FRCS · Iladevi Cataract and IOL Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01385878 on ClinicalTrials.gov